Form D — Biolexis Therapeutics Inc.
0001914060-26-000001 · filed Jun 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $12,000,000
- Reported amount sold
- $1,600,000
- Minimum investment
- $0
- Investors
- 2
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Biolexis Therapeutics Inc.
- CIK
- 1914060
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3900 N TRAVERSE MOUNTAIN BLVD
LEHI, UT 84043 - Phone
- 801-328-3600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Tyler Hartmann · Executive OfficerLehi, UT Find on LinkedIn ↗
-
David J. Bearss · DirectorLehi, UT Find on LinkedIn ↗
-
Hariprasad Vankayalapati · DirectorLehi, UT Find on LinkedIn ↗
-
James N. Clarke · DirectorLehi, UT Find on LinkedIn ↗
-
Anthony Steve · DirectorLehi, UT Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗